Biotron Ltd Buy Hold or Sell Recommendation

BITRF -- USA Stock  

USD 0.024  0.02  45.45%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Biotron Ltd Ord is 'Strong Sell'. Macroaxis provides Biotron Ltd buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BITRF positions. The advice algorithm takes into account all of Biotron Ltd Ord available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BITRF buy-and-hold prospective. Check also Biotron Ltd Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Biotron LtdBuy Biotron Ltd
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon Biotron Ltd Ord has a mean deviation of 2.75, semi deviation of 0.0, standard deviation of 7.26, variance of 52.78, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Biotron Ltd Ord. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Biotron Ltd is not overpriced, please confirm all Biotron Ltd Ord fundamentals including its Gross Profit and the relationship between Current Ratio and Working Capital . As Biotron Ltd Ord appears to be a penny stock we also recommend to validate its Price to Book numbers.

Biotron Ltd Trading Alerts and Improvement Suggestions

Biotron Ltd Ord generates negative expected return over the last 30 days
Biotron Ltd Ord has high historical volatility and very poor performance
Biotron Ltd Ord has some characteristics of a very speculative penny stock
Biotron Ltd Ord has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 1.2 M. Net Loss for the year was (1.18 M) with profit before overhead, payroll, taxes, and interest of 1.07 M.
BIOTRON LTD has accumulated about 1.14 M in cash with (1.36 M) of positive cash flow from operations.
Latest headline from Global Electroporation Instruments Market Research Segment, In-depth Analysis Thermo Fisher Scientific, Bio-Rad Laboratories, Lonza - 5Gigs News

Biotron Ltd Returns Distribution Density

Mean Return0.92Value At Risk7.88
Potential Upside1.96Standard Deviation7.26
 Return Density 

Biotron Ltd Greeks

Alpha over DOW
Beta against DOW=0.94
Overall volatility
Information ratio =0.14

Biotron Ltd Volatility Alert

Biotron Ltd Ord is displaying above average volatility of 7.26 over selected time horizon. Investors should scrutinize Biotron Ltd Ord independently to make sure intended market timing strategies are aligned with expectations about Biotron Ltd volatility. Biotron Ltd Ord is a penny stock. Although Biotron Ltd may be in fact a good investment, many penny stocks are subject to artificial stock hype. Make sure you completely understand upside potential and downside risk of investing in Biotron Ltd Ord. We encourage investors to look for the signals such us message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare Biotron Ltd to competition

Biotron Ltd Fundamental Vs Peers

FundamentalsBiotron LtdPeer Average
Return On Equity(47.97) (0.31) 
Return On Asset(28.44) (0.14) 
Profit Margin(150.24) (1.27) 
Current Valuation26.21 M16.62 B
Shares Outstanding609.47 M571.82 M
Price to Earning(3.04) 28.72 
Price to Book22.00 9.51 
Price to Sales51.63 11.42 
Revenue1.2 M9.43 B
Gross Profit1.07 M27.38 B
EBITDA(1.18 M)3.9 B
Net Income(1.18 M)570.98 M
Cash and Equivalents1.14 M2.7 B
Current Ratio14.02 2.16 
Cash Flow from Operations(1.36 M)971.22 M
Earnings Per Share(0.003) 3.12 
Number of Employees318.84 K
Market Capitalization24.63 M19.03 B
Total Asset3 M29.47 B
Retained Earnings(37 M)9.33 B
Working Capital3 M1.48 B
Current Asset3 M9.34 B
Z Score-15.68.72